Rossella Elisei Selected Research

Rossella Elisei Research Topics

Disease

67	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 09/2002
48	Neoplasms (Cancer) 10/2022 - 09/2002
21	medullary Thyroid cancer 01/2022 - 01/2004
16	Papillary Thyroid Cancer 02/2021 - 12/2002
9	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2002
8	Anaplastic Thyroid Carcinoma 02/2021 - 02/2003
7	Thyroid Nodule (Nodule, Thyroid) 01/2019 - 12/2002
7	Disease Progression 01/2016 - 08/2009
6	Fatigue 01/2021 - 10/2013
6	Hypertension (High Blood Pressure) 09/2016 - 01/2012
5	Lymphatic Metastasis 01/2022 - 10/2007
5	Hypothyroidism 01/2022 - 09/2002
5	Nausea 09/2016 - 01/2012
5	Diarrhea 01/2016 - 01/2012
4	Adenoma (Adenomas) 11/2011 - 05/2003
3	Thyrotoxicosis 01/2022 - 12/2005
3	Thyroid Diseases (Thyroid Disease) 12/2016 - 01/2004
3	Exanthema (Rash) 09/2016 - 01/2012
3	Carcinoma (Carcinomatosis) 05/2004 - 05/2003
2	Dermatitis 10/2022 - 09/2016
2	Goiter 01/2022 - 11/2004
2	Fistula 01/2022 - 07/2021
2	Carcinogenesis 10/2021 - 02/2021
2	Weight Loss (Weight Reduction) 01/2021 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2003
2	Headache (Headaches) 09/2016 - 01/2012
2	Overweight 06/2014 - 07/2005
2	Nodular Goiter 03/2013 - 11/2004
2	Autoimmune Diseases (Autoimmune Disease) 07/2008 - 09/2003
2	Congenital Hypothyroidism (Cretinism) 10/2003 - 09/2003
1	Hypoparathyroidism 11/2022
1	Malnutrition (Nutritional Deficiencies) 03/2022
1	Cachexia 03/2022
1	Hyperthyroidism 09/2021
1	Body Weight (Weight, Body) 07/2021
1	Drug-Related Side Effects and Adverse Reactions 07/2021

Drug/Important Bio-Agent (IBA)

18	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022 - 01/2004
15	lenvatinibIBA 01/2022 - 02/2015
11	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2013
10	IodineIBA 10/2022 - 04/2005
9	AntibodiesIBA 09/2021 - 02/2003
9	Thyroglobulin FDA Link 08/2020 - 01/2004
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
8	vandetanib (ZD6474)IBA 01/2021 - 01/2012
7	Messenger RNA (mRNA)IBA 10/2021 - 02/2003
6	cabozantinibIBA 01/2022 - 08/2013
6	prolinedithiocarbamate (PDTC)IBA 03/2021 - 04/2016
6	Biological ProductsIBA 02/2021 - 11/2004
5	Pharmaceutical PreparationsIBA 10/2022 - 08/2013
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2003
5	Capsules (Microcapsules)IBA 01/2022 - 11/2007
5	Thyrotropin Alfa FDA LinkGeneric 01/2020 - 09/2002
4	RNA (Ribonucleic Acid)IBA 10/2017 - 05/2003
4	sodium-iodide symporter (sodium iodide symporter)IBA 06/2008 - 09/2003
3	Thyroid HormonesIBA 01/2022 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2006
3	Protein Isoforms (Isoforms)IBA 10/2021 - 09/2008
3	Galectin 3 (LGALS3)IBA 01/2021 - 08/2003
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020 - 09/2002
3	anti-thyroglobulinIBA 01/2018 - 04/2012
3	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 07/2014
3	AntigensIBA 09/2015 - 02/2003
3	Carcinoembryonic AntigenIBA 09/2015 - 04/2012
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2015 - 08/2009
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2015 - 08/2009
3	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2005 - 09/2002
2	Phosphotransferases (Kinase)IBA 01/2022 - 09/2012
2	AutoantibodiesIBA 01/2020 - 07/2008
2	MicroRNAs (MicroRNA)IBA 03/2019 - 01/2019
2	Iodine-131IBA 01/2019 - 02/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2008
2	Angiopoietin-2IBA 01/2016 - 08/2015
2	CarbohydratesIBA 09/2015 - 09/2013
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2015 - 02/2015
2	Codon (Codons)IBA 06/2015 - 12/2011
2	fosbretabulin (combretastatin A4)IBA 02/2014 - 12/2012
2	Tumor Biomarkers (Tumor Markers)IBA 10/2013 - 09/2013
2	NucleotidesIBA 03/2011 - 05/2004
1	AZD 6244IBA 10/2022
1	Monoclonal AntibodiesIBA 07/2022
1	TabletsIBA 01/2022
1	selpercatinibIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	EnzymesIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2021
1	Apoptosis Regulatory ProteinsIBA 09/2021
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 09/2021

Therapy/Procedure

26	Therapeutics 03/2022 - 09/2002
15	Thyroidectomy 01/2022 - 12/2002
2	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 08/2020
2	Immunotherapy 09/2021 - 02/2003
2	Radiotherapy 07/2021 - 04/2005
2	Drug Tapering 07/2021 - 10/2013
2	Drug Therapy (Chemotherapy) 04/2005 - 09/2002
1	Operative Time 11/2022
1	Length of Stay 11/2022
1	Conservative Treatment 01/2022
1	Operative Surgical Procedures 01/2022
1	Precision Medicine 01/2022